Inventor
QU ZHENGXING
US64 patents
⚠️ This page may combine multiple inventors who share the name “QU ZHENGXING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
IMMUNOMEDICS INC
39 patentsUS7931903B2Apr 26, 2011
Internalizing anti-CD74 antibodies and methods of use
IMMUNOMEDICS INC97 citations99
US7772373B2Aug 10, 2010
Internalizing anti-CD74 antibodies and methods of use
IMMUNOMEDICS INC114 citations99
US7312318B2Dec 25, 2007
Internalizing anti-CD74 antibodies and methods of use
IMMUNOMEDICS INC243 citations99
US7300655B2Nov 27, 2007
Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof
IMMUNOMEDICS INC109 citations99
US7151164B2Dec 19, 2006
Anti-CD20 antibodies and fusion proteins thereof and methods of use
IMMUNOMEDICS INC290 citations99
US7109304B2Sep 19, 2006
Humanized anti-CD19 antibodies
IMMUNOMEDICS INC240 citations99
US6962702B2Nov 8, 2005
Production and use of novel peptide-based agents for use with bi-specific antibodies
IMMUNOMEDICS INC126 citations99
US6472511B1Oct 29, 2002
Stimulation of an immune response with antibodies labeled with the α-galactosyl epitope
IMMUNOMEDICS INC160 citations99
US6254868B1Jul 3, 2001
Glycosylated humanized B-cell specific antibodies
IMMUNOMEDICS INC206 citations99
US8992917B2Mar 31, 2015
Humanized L243 antibodies
IMMUNOMEDICS INC37 citations98
US7902338B2Mar 8, 2011
Anti-CD19 antibodies
IMMUNOMEDICS INC47 citations98
US7462352B2Dec 9, 2008
Methods of treatng B-cell diseases using humanized anti-CD19 antibodies
IMMUNOMEDICS INC74 citations98
US7282567B2Oct 16, 2007
Monoclonal antibody hPAM4
IMMUNOMEDICS INC143 citations98
US7238785B2Jul 3, 2007
RS7 antibodies
IMMUNOMEDICS INC237 citations98
US7919087B2Apr 5, 2011
Internalizing anti-CD74 antibodies and methods of use
IMMUNOMEDICS INC33 citations96
US7612180B2Nov 3, 2009
Humanized L243 antibodies
IMMUNOMEDICS INC102 citations96
US7537930B2May 26, 2009
Mammalian cell lines for increasing longevity and protein yield from a cell culture
IMMUNOMEDICS INC30 citations96
US7517964B2Apr 14, 2009
RS7 antibodies
IMMUNOMEDICS INC68 citations96
US7074405B1Jul 11, 2006
Use of bi-specific antibodies for pre-targeting diagnosis and therapy
IMMUNOMEDICS INC61 citations96
US6090381AJul 18, 2000
Stimulation of an immune response with antibodies labeled with the . .alpha-galactosyl epitope
IMMUNOMEDICS INC46 citations96
US8758752B2Jun 24, 2014
RS7 antibodies
IMMUNOMEDICS INC16 citations93
US8361464B2Jan 29, 2013
Anthracycline-Antibody Conjugates for Cancer Therapy
IMMUNOMEDICS INC18 citations93
US7501498B2Mar 10, 2009
Alpha-fetoprotein Immu31 antibodies and fusion proteins
IMMUNOMEDICS INC16 citations93
US7435803B2Oct 14, 2008
Anti-CD20 antibodies and fusion proteins thereof and methods of use
IMMUNOMEDICS INC32 citations93
US7429381B2Sep 30, 2008
Production and use of novel peptide-based agents for use with bi-specific antibodies
IMMUNOMEDICS INC14 citations93
US7052872B1May 30, 2006
Bi-specific antibodies for pre-targeting diagnosis and therapy
IMMUNOMEDICS INC49 citations93
US6953675B2Oct 11, 2005
Landscaped antibodies and antibody fragments for clinical use
IMMUNOMEDICS INC43 citations93
US7785880B2Aug 31, 2010
Mammalian cell lines for increasing longevity and protein yield from cell culture
IMMUNOMEDICS INC21 citations92
US7531327B2May 12, 2009
Methods and compositions for increasing longevity and protein yield from a cell culture
IMMUNOMEDICS INC30 citations90
US7230085B2Jun 12, 2007
Anti-DOTA antibody
IMMUNOMEDICS INC25 citations90
US10179171B2Jan 15, 2019
RS7 antibodies
IMMUNOMEDICS INC7 citations84
US9999668B2Jun 19, 2018
RS7 antibodies
IMMUNOMEDICS INC3 citations84
US9849176B2Dec 26, 2017
RS7 antibodies
IMMUNOMEDICS INC5 citations84
US9833511B2Dec 5, 2017
RS7 antibodies
IMMUNOMEDICS INC3 citations84
US9056917B2Jun 16, 2015
Anti-CD19 antibodies
IMMUNOMEDICS INC5 citations84
US8568729B2Oct 29, 2013
Anthracycline-antibody conjugates for cancer therapy
IMMUNOMEDICS INC7 citations84
US8486395B2Jul 16, 2013
Anti-CD19 antibodies
IMMUNOMEDICS INC5 citations84
US8624001B1Jan 7, 2014
Anti-CD19 antibodies
IMMUNOMEDICS INC3 citations74
US7951921B2May 31, 2011
Multivalent carriers of bi-specific antibodies
IMMUNOMEDICS INC6 citations74
HANSEN HANS J
4 patentsUS8337840B2Dec 25, 2012
Anti-CD19 antibodies
HANSEN HANS J10 citations92
US8147831B2Apr 3, 2012
Anti-CD19 antibodies
HANSEN HANS J16 citations92
US8084029B2Dec 27, 2011
Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof
HANSEN HANS J8 citations84
US8188239B2May 29, 2012
Multivalent carriers of bi-specific antibodies
HANSEN HANS J5 citations74
GOLDENBERG DAVID M
2 patentsGOVINDAN SERENGULAM V
2 patentsHANSEN HANS
1 patentGOVINDAN SERENGULAM
1 patentDANA FARBER CANCER INST INC
1 patentShowing the top 50 of 64 patents by PatentIndex Score.